{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:38:42Z","timestamp":1790008722888,"version":"4.0.1"},"reference-count":27,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Reports for atypical squamous cells of undetermined significance (ASC-US) and histologic findings are rare in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To analyze the correlation findings of ASC-US cytology with high-risk human papillomavirus (hrHPV) test and histopathologic follow-ups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>ASC-US cases with hrHPV test and histologic follow-ups between 2011 and 2015 were analyzed at a College of American Pathologists\u2013certified laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>A total of 2\u2009206\u2009588 Papanicolaou (Pap) tests were performed, including 1\u2009513\u2009265 liquid-based cytology preparations (68.58%), and 693\u2009323 conventional Pap tests (31.42%). The overall ASC-US reporting rate was 3.77% (83\u2009199 of 2\u2009206\u2009588), with the highest in women aged 40 to 49 years. Of 18\u2009574 women with ASC-US Pap and HPV testing, the hrHPV positivity rate was 34.98% (6498 of 18\u2009574) with the highest in women younger than 30 years. A total of 6012 women with ASC-US Pap test findings had histologic follow-ups within 6 months; the overall cervical intraepithelial neoplasia 2 and above (CIN2+) detection rate was 7.87% (473 of 6012). One thousand nine hundred nine women with ASC-US Pap and HPV testing had histologic results. CIN2+ lesion was found in 13.98% (124 of 887) of women with ASC-US Pap\/HPV-positive test results, significantly higher than 2.84% (29 of 1022) for women with ASC-US Pap\/HPV-negative test results. Cervical squamous cell carcinoma was found in 3.95% (35 of 887) of women with ASC-US\/HPV-positive test results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>This is one of the largest studies to investigate HPV and histologic follow-up findings in women with ASC-US in China. The ASC-US reporting rate, HPV positivity rate, and CIN2+ detection rate were all within the currently recognized benchmark ranges. These findings may contribute to establishing a baseline for better understanding of the status of cervical screening in China.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2018-0244-oa","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T10:37:19Z","timestamp":1546511839000},"page":"748-752","source":"Crossref","is-referenced-by-count":10,"title":["Atypical Squamous Cells of Undetermined Significance Cervical Cytology Report Rate and Histologic Follow-up Findings From the Largest College of American Pathologists\u2013Certified Laboratory in China"],"prefix":"10.5858","volume":"143","author":[{"given":"Baowen","family":"Zheng","sequence":"first","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaitao","family":"Yang","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaibo","family":"Li","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"You","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijian","family":"Wei","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Zhang","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Zeng","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Xie","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"From Guangzhou Kingmed Diagnostics, Guangzhou, Guangdong, China (Drs Zheng, You, Wei, and Mr Zeng); the Department of Pathology, Conemaugh Health System, Johnstown, Pennsylvania (Dr Yang); the Department of Pathology, Wexner Medical Center at Ohio State University, Columbus (Dr Li); the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2018,12,28]]},"reference":[{"issue":"suppl 12","key":"2020081203292082600_i1543-2165-143-6-748-b01","doi-asserted-by":"crossref","first-page":"M53","DOI":"10.1016\/j.vaccine.2008.05.009","article-title":"Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia","volume":"26","author":"Shi","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"2020081203292082600_i1543-2165-143-6-748-b02","first-page":"1149","article-title":"Review of the cervical cancer disease burden in mainland China","volume":"12","author":"Li","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"2020081203292082600_i1543-2165-143-6-748-b03","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5858\/arpa.2014-0070-OA","article-title":"Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1394389 Papanicolaou test reports","volume":"139","author":"Zheng","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2020081203292082600_i1543-2165-143-6-748-b04","first-page":"84","article-title":"PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory","volume":"4","author":"Zheng","year":"2014","journal-title":"JASC"},{"issue":"3","key":"2020081203292082600_i1543-2165-143-6-748-b05","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5858\/134.3.331","article-title":"Practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology, 2006","volume":"134","author":"Eversole","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081203292082600_i1543-2165-143-6-748-b06","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jinf.2018.02.008","article-title":"Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: a systematic review","volume":"76","author":"Zhou","year":"2018","journal-title":"J Infect"},{"issue":"2","key":"2020081203292082600_i1543-2165-143-6-748-b07","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mob.2001.116736","article-title":"Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy","volume":"185","author":"Bernstein","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2020081203292082600_i1543-2165-143-6-748-b08","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"2020081203292082600_i1543-2165-143-6-748-b09","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10552-015-0549-9","article-title":"Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance","volume":"26","author":"Watson","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2020081203292082600_i1543-2165-143-6-748-b10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"7609","key":"2020081203292082600_i1543-2165-143-6-748-b11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomized controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"issue":"16","key":"2020081203292082600_i1543-2165-143-6-748-b12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"2020081203292082600_i1543-2165-143-6-748-b13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ajcp\/101.2.215","article-title":"Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor","volume":"101","author":"Hutchinson","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2020081203292082600_i1543-2165-143-6-748-b14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1582-4934.2008.00631.x","article-title":"Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate","volume":"13","author":"Arbyn","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2020081203292082600_i1543-2165-143-6-748-b15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.5858\/arpa.2014-0393-CP","article-title":"Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists national survey","volume":"139","author":"Zhao","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"5 suppl 1","key":"2020081203292082600_i1543-2165-143-6-748-b16","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","article-title":"Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"2020081203292082600_i1543-2165-143-6-748-b17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","author":"ASCUS-LSIL Triage Study (ALTS) Group","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2020081203292082600_i1543-2165-143-6-748-b18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/dc.21209","article-title":"Women &gt;or=30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women?","volume":"38","author":"Thrall","year":"2010","journal-title":"Diagn Cytopathol"},{"issue":"51","key":"2020081203292082600_i1543-2165-143-6-748-b19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13510","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"issue":"10","key":"2020081203292082600_i1543-2165-143-6-748-b20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaoncol.2017.1040","article-title":"Outcomes in women with cytology showing atypical squamous cells of undetermined significance with vs without human papillomavirus testing","volume":"3","author":"Cuzick","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"2020081203292082600_i1543-2165-143-6-748-b21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/LGT.0000000000000343","article-title":"Risks of CIN 2+, CIN 3+, and cancer by cytology and human papillomavirus status: The Foundation of Risk-Based Cervical Screening Guidelines","volume":"21","author":"Demarco","year":"2017","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"2020081203292082600_i1543-2165-143-6-748-b22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2020081203292082600_i1543-2165-143-6-748-b23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.5858\/133.9.1426","article-title":"Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice","volume":"133","author":"Armah","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"2020081203292082600_i1543-2165-143-6-748-b24","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/ijc.27571","article-title":"Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies","volume":"131","author":"Zhao","year":"2012","journal-title":"Int J Cancer"},{"issue":"17","key":"2020081203292082600_i1543-2165-143-6-748-b25","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.7314\/APJCP.2015.16.17.7401","article-title":"Review of the cervical cancer burden and population-based cervical cancer screening in China","volume":"16","author":"Di","year":"2015","journal-title":"Asia Pacific J Cancer Prev"},{"issue":"2","key":"2020081203292082600_i1543-2165-143-6-748-b26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2020081203292082600_i1543-2165-143-6-748-b27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/6\/748\/2368319\/arpa_2018-0244-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/6\/748\/2368319\/arpa_2018-0244-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:25Z","timestamp":1764790585000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/143\/6\/article-p748.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,28]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,28]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0244-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,28]]}}}